Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • April 21, 2015:

    A new research study has shown that pancreatic cancer cells can be coaxed to revert back toward normal cells by introducing a protein called E47. E47 binds to specific DNA sequences and controls genes involved in growth and differentiation. The research provides hope for a new treatment approach for the more than 40,000 people who die from the disease that is called the “silent” cancer because it rarely shows early symptoms—it tends to be diagnosed at advanced stages when it causes weight loss, abdominal pain, and jaundice. Then it’s too late.Full Story

  • April 20, 2015:

    Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices used to extract life-threatening blood clots in the brain. When blood supply to the brain is significantly diminished or blocked, an acute stroke may result, requiring quick medical intervention to avoid permanent brain damage or death for the 795,000 Americans who experience a stroke each year. The artificial vessel could have significant implications for future development of endovascular technologies.Full Story

  • April 17, 2015:

    During an epileptic seizure, the nerve cells in a specific area of the brain are suddenly activated in an excessive manner. How can this phenomenon be controlled without affecting healthy brain regions? To answer this question, Christophe Bernard's team, in collaboration with a team led by George Malliaras at the Georges Charpak-Provence Campus of the École des Mines of Saint-Étienne and Swedish scientists led by Magnus Berggren from Linköping University, have developed a biocompatible micropump that delivers therapeutic substances directly to the relevant areas of the brain.Full Story

  • April 16, 2015:

    Tasso Inc. has just received an additional $3 million from the Defense Advanced Research Projects Agency (DARPA) to perfect a device the size of a ping pong ball that extracts a small sample while held against the skin for two minutes.

    Casavant says, "We see our specialty as people who need to test semi-frequently, or infrequently, to monitor cancer or chronic infectious diseases, for example. Instead of buying a machine or expensive equipment, we ship you this device, you put it on your arm for two minutes and send it back to the lab."Full Story

  • April 14, 2015:

    An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. "This is the first study to show preservation of vision after a single injection of adult-derived human cells into a rat model with age-related macular degeneration," said Shaomei Wang, MD, PhD, lead author of the study published in the journal STEM CELLS and a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute.Full Story

  • April 10, 2015:

    Pancreatic cancer mortality is high, owing to the fact that many cases are diagnosed late stage, yet routine screening of those at average risk is not practical. A recent study published online in JAMA Surgery using an MRI-based screening program conducted by Marco Del Chiaro, MD, PhD, of the Karolinska Institute in Stockholm, showed promising early results.Full Story

  • April 6, 2015:

    The Allen Institute for Brain Science is spearheading a landmark international effort to define and advance the state-of-the-art digital reconstruction and analysis of single neurons. Today, there are no standards to compare algorithms developed on different platforms, using and different standards of analysis. As a result, these large data sets cannot be analyzed and compared as a whole.
    The Big Neuron project is a partnership including schools, government agencies and other organizations which aim to create reliable high-throughput and quantitative 3D reconstructions of the thousands of branches that make up individual neurons: a crucial step to ultimately understanding how the brain encodes information.Full Story

  • March 31, 2015:

    Donald Spector, inventor of the patent has donated it to the New York College of Health Professions.The device allows surgeons to view and compare what they are seeing as if it were in the traditional format of a slide that is used during biopsies, and match it against medical databases during surgery, thus providing the surgeon real time analysis and information. Donald Spector says, "The combination of surgical expertise with what the surgeon sees, coupled with the real time analysis using the latest internet technology and artificial intelligence is an exciting project that has the potential to revolutionize medicine and hopefully save lives."Full Story

  • March 31, 2015:

    A world-first collaboration that uses imaging technology, developed by high-tech German optical measurement manufacturer Zeiss and Google algorithms has allowed Professor Knothe Tate – an engineer and expert in cell biology and regenerative medicine –to zoom in and out from the scale of the whole joint down to the cellular level “just as you would with Google Maps,” reducing to “a matter of weeks’ analyses that once took 25 years to complete”.Full Story

  • March 26, 2015:

    Apple just announced ResearchKit, a platform for app builders to capture and upload personal medical data. Companies such as Google, Microsoft, and Samsung and hundreds of start-ups are also eyeing the $3 trillion health care industry to disrupt it in the same way Netflix decimated the video-rental industry and Uber is changing transportation.

    These companies plan to use nano-sensors that monitor almost every aspect of our body’s functioning, inside and out. They will be packaged in watches, Band-Aids, clothing, and contact lenses. The data from these will be uploaded into cloud-based platforms such as Apple’s HealthKit. Then, artificial intelligence–based apps will monitor and advise us on what actions/medications we should take to improve our lifestyle and habits.Full Story

  • March 26, 2015:

    Google has secured a patent for a potentially cancer cell-destroying wrist-worn device. The device would make use of functionalized particles in the blood, which are able to selectively bind to targets that often have adverse health effects. Once the targets have been acquired, the wearable device generates energy and sends it to the blood vessels, allowing the targets to be selectively modified or completely destroyed.Full Story

  • March 26, 2015:

    Thanks to a new hand-held instrument developed in the Hansma Lab at UC Santa Barbara called OsteoProbe, doctors are able to measure bone loss according to trial results reported in the Journal of Bone and Mineral Research. OsteoProbe uses reference point indentation (RPI) to measure mechanical properties of bone at the tissue level. This capability is especially useful for people taking glucocorticoids such as prednisone, where bone loss and the increased risk of bone fracture is a well-documented side effect.Full Story

  • March 23, 2015:

    CardioKinetix Inc., announced the three-month clinical and echocardiographic results of a catheter-based treatment for heart failure called PARACHUTE China which studied 31 Chinese patients treated consecutively with the company’s Parachute Ventricular Partitioning Device.
    “The results of this study, which met its primary and secondary endpoints, continue to substantiate the safety profile and effectiveness of the Parachute as a viable minimally invasive ventricular partitioning device for patients with ischemic heart failure,” said Gao Runlin, M.D., chief cardiologist at Fu Wai Hospital, Chinese Academy of Medical Sciences who presented the results at the China Interventional Therapeutics (CIT) 2015 conference in Beijing.Full Story

  • March 18, 2015:

    Ben-Gurion University of the Negev (BGU) researchers has developed a groundbreaking approach to determine sleep quality using their new breath sound analysis (BSA). This is less expensive and invasive than current polysomnography (PSG) technology.
    "We've developed a non-contact 'breathing sound analysis' algorithm that provides a reliable estimation of whole-night sleep evaluation for detection of sleep quality, snoring severity and Obstructive Sleep Apnea (OSA). It has the potential to reduce the cost and management of sleep disorders compared to PSG, the current standard of treatment." says Prof. Yaniv Zigel Ph.D., head of the Biomedical Signal Processing Research Lab in BGU's Department of Biomedical Engineering. Full Story